Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Yongzhong Wu
Yongchun Pan
Mei Li
Jiacheng Zhou
Zhongjiang Jia
Pingli Liu
Shili Chen
Date of Patent
September 19, 2023
Patent Application Number
17520264
Date Filed
November 5, 2021
Patent Citations
...
Patent Citations Received
Patent Primary Examiner
CPC Code
Patent abstract
The present invention relates to crystalline forms of the PD-1/PD-L1 inhibitor (R)-1-((7-cyano-2-(3′-(3-(((R)-3-hydroxypyrrolidin-1-yl)methyl)-1,7-naphthyridin-8-ylamino)-2,2′-dimethylbiphenyl-3-yl)benzo[d]oxazol-5-yl)methyl)pyrrolidine-3-carboxylic acid, including methods of preparation thereof, and related synthetic intermediates, where the compound is useful in the treatment of various diseases including infectious diseases and cancer.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
